ClinicalTrials.Veeva

Menu
S

Spartanburg Medical Research | Spartanburg, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
Tiotropium
Metformin
Sugar
Lubiprostone
SUN-101
Ensifentrine
Lasmiditan
Tirzepatide
Cagrilintide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

13 of 99 total trials

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide (AMAZE 7)

The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treat...

Begins enrollment this month
Overweight
Obesity
Drug: Placebo (matched to zenagamtide)
Drug: Semaglutide
Locations recently updated

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight....

Enrolling
Obesity
Type 2 Diabetes
Drug: Cagrisema
Drug: Semaglutide

This study will look at how well CagriSema helps people living with obesity to lose weight and maintain the weight loss long-term. The study has 2 pa...

Active, not recruiting
Obesity
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)
Drug: CagriSema (Cagrilintide B and Semaglutide I)

This study will look at how well CagriSema helps people with obesity lose weight compared to a "dummy medicine". CagriSema is a new medicine develope...

Active, not recruiting
Obesity
Drug: Semaglutide
Drug: Placebo cagrilintide
Locations recently updated

This study has 2 parts: First part is the main study and second part is the extension study. During the main study participants will receive 1 of 4 s...

Active, not recruiting
Obesity
Drug: Cagrilintide
Drug: Semaglutide

The goal of this clinical study is to learn if giving repeated annual doses of MK-1406 (CD388) is safe and how the body reacts to it in healthy adult...

Active, not recruiting
Healthy Participants
Combination Product: MK-1406 Injection

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting
Influenza
Combination Product: CD388 Injection
Combination Product: Placebo

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

This study aims to find out whether a study medicine called survodutide helps people control their blood sugar. Adults who live with type 2 diabetes...

Enrolling
Type 2 Diabetes
Drug: Survodutide
Drug: Placebo

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and type 2 di...

Enrolling
Overweight
Diabetes Mellitus
Drug: NNC0487-0111
Drug: Placebo (matched to NNC0487-0111)

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 s...

Not yet enrolling
Overweight
Obesity
Drug: zenagamtide
Drug: Placebo

The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body wei...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Semaglutide

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilintide is a...

Active, not recruiting
Overweight
Obesity
Drug: Cagrilintide
Drug: Placebo (matched to Cagrilintide)

Trial sponsors

Novo Nordisk logo
Boehringer Ingelheim logo
Moderna logo
Pfizer logo
Genentech logo
P
S
Sunovion logo
C
AstraZeneca logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems